{"filing":{"accession_number":"0001193125-26-301997","cik":"0001563577","ticker":"GRTX","company_name":"Galera Therapeutics, Inc.","form":"8-K","filing_date":"2026-07-13","report_date":null,"primary_document":"d155293d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526301997/d155293d8k.htm"},"events":[{"id":17580,"run_id":15747,"accession_number":"0001193125-26-301997","anchor_item_number":"5.03","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"The Company effected a 1:200 reverse stock split on July 12, 2026, through an amendment to its Restated Certificate of Incorporation, materially affecting the Company's share structure, trading symbol, and the exercise prices of outstanding options and warrants.","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-13","form":"8-K","submitted_at":null,"items":[{"id":16107,"accession_number":"0001193125-26-301997","item_number":"3.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.65,"reasoning":"Item 3.03 discloses a material modification to rights of security holders by incorporating Item 5.03 by reference. Item 5.03 typically covers amendments to articles of incorporation, bylaws, or charter documents. Without the full text of Item 5.03, the specific nature of the modification cannot be determined, but the disclosure of any material modification to security holder rights is a governance matter affecting the registrant's capital structure or voting arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:01:47.329748+00:00","company_name":"","ticker":null,"filing_date":""},{"id":16108,"accession_number":"0001193125-26-301997","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure describes a 1:200 reverse stock split effected on July 12, 2026, through an amendment to the Company's Restated Certificate of Incorporation. While a reverse stock split is a governance event (amendment to articles of incorporation), it does not fit the specific governance categories (exec_departure, exec_appointment, exec_compensation, shareholder_vote_results, auditor_change). The event is material to investors as it affects share structure, trading symbol, and exercise prices of options and warrants, making it a governance_other classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:01:47.329748+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16107,"accession_number":"0001193125-26-301997","item_number":"3.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.65,"reasoning":"Item 3.03 discloses a material modification to rights of security holders by incorporating Item 5.03 by reference. Item 5.03 typically covers amendments to articles of incorporation, bylaws, or charter documents. Without the full text of Item 5.03, the specific nature of the modification cannot be determined, but the disclosure of any material modification to security holder rights is a governance matter affecting the registrant's capital structure or voting arrangements.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:01:47.329748+00:00","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-13"},{"id":16108,"accession_number":"0001193125-26-301997","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This disclosure describes a 1:200 reverse stock split effected on July 12, 2026, through an amendment to the Company's Restated Certificate of Incorporation. While a reverse stock split is a governance event (amendment to articles of incorporation), it does not fit the specific governance categories (exec_departure, exec_appointment, exec_compensation, shareholder_vote_results, auditor_change). The event is material to investors as it affects share structure, trading symbol, and exercise prices of options and warrants, making it a governance_other classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-13T20:01:47.329748+00:00","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-13"}]}